breast cancer research

  Breakthrough research shows that primary breast cancer has the ability to "essentially shut down its own spread." These findings may help "freeze" cancer cells before they get chance to form secondary tumors. According to the National Cancer Institute (NCI), in the United States, a total of 266,120 women will be diagnosed with breast cancer in 2018. Almost 41,000 of these cases will result in death. However, as the NCI show, the number of breast cancer deaths

A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology. The researchers were able to isolate relevant data to more accurately identify breast cancer biomarkers using two different electronic nose gas sensors for breath, along with gas-chromatography mass spectrometry (GC-MS) to quantify substances found in urine. In their study

The American Society for Radiation Oncology (ASTRO) has put out updated guidelines on whole-breast radiation therapy. The updated guidelines say that most women diagnosed with breast cancer should be treated with accelerated whole-breast irradiation as the standard of care. The new guideline greatly increases the number of women recommended to have accelerated whole-breast irradiation. The updated guidelines were published online on March 12, 2018 by the journal Practical Radiation Oncology.

Mutations in known breast cancer genes such as BRCA1 and BRCA2 are identified in only approximately 20 per cent of women who are offered genetic testing for familial breast cancer. Researchers at the University of Melbourne, led by Professor Melissa Southey, looked at 210 people from 25 multiple-case breast cancer families. They identified 24 previously unknown epigenetic changes that alter a woman's risk of breast cancer and can be passed down through generations without involving